Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-<i>N</i>-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis
Distribution of the number of citations over years.